ProFibrix Raises $11 Million
ProFibrix BV, a Dutch developer of products for hemostasis and regenerative medicine, has raised $11 million in Series B funding. Gilde Healthcare Partners led the round, and was joined by return backer Index Ventures.
24 August 2009•3 mins read
